幽門螺旋桿菌診斷市場規模、佔有率和成長分析（按檢測類型、方法、最終用戶和地區）- 產業預測 2025-2032

2023 年全球幽門螺旋桿菌診斷市場規模為 6.312 億美元，預計將從 2024 年的 6.7475 億美元成長到 2032 年的 11.5071 億美元，預測期內（2025-2032 年）的複合年成長率為 6.9%。

隨著早期檢測對於加強疾病管理和降低醫療成本的重要性日益增加，幽門螺旋桿菌診斷市場正在獲得發展動力。診斷測試，包括血液檢查、呼吸檢測和糞便抗原測試，可以準確識別幽門螺旋桿菌病菌感染並促進及時干預，從而改善患者的治療效果。早期治療可以緩解症狀，加速潰瘍癒合，並避免胃癌等嚴重併發症。非侵入性、經濟高效的檢測方式的出現，使得更多的患者能夠接受這種檢測。此外，治療方法包括各種有效的抗生素和抑酸藥，不僅可以緩解症狀，還可以降低消化性潰瘍的風險，最終改善患者的生活品質。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 宏觀經濟指標
• 價值鏈分析
• 定價分析

幽門螺旋桿菌診斷藥物市場規模（依檢測類型）

• 市場概況
• 侵入性
• 組織學
• 快速尿素酶檢測
• 惠普文化
• 非侵入性
• 血清學檢測
• 尿素呼吸檢測
• 糞便抗原檢測

幽門螺旋桿菌診斷藥物市場規模（依方法）

• 市場概況
• 免疫檢測
• 分子診斷
• 照護現場(POC)
• 其他

幽門螺旋桿菌診斷藥物市場規模（按最終用戶分類）

• 市場概況
• 醫院
• 診所
• 診斷實驗室
• 其他

幽門螺旋桿菌診斷藥物市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Thermo Fisher Scientific（USA）
• Bio-Rad Laboratories（USA）
• Meridian Bioscience（USA）
• F. Hoffmann-La Roche Ltd.（Switzerland）
• Quest Diagnostics Incorporated（USA）
• Abbott Laboratories（USA）
• BioMerieux SA（France）
• Cardinal Health, Inc.（USA）
• Epitope Diagnostics, Inc.（USA）
• Biohit Oyj（Finland）
• Avanos Medical, Inc.（USA）
• Quidel Corporation（USA）
• DiaSorin SpA（Italy）
• Agilent Technologies, Inc.（USA）
• Laboratory Corporation of America Holdings（LabCorp）（USA）
• Siemens Healthineers AG（Germany）

結論和建議

Global Helicobacter pylori H. pylori Diagnostics Market size was valued at USD 631.2 million in 2023 and is poised to grow from USD 674.75 million in 2024 to USD 1150.71 million by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).

The H. pylori diagnostics market is gaining traction, driven by the rising importance of early detection for enhanced disease management and reduced healthcare costs. Diagnostic tests such as blood, breath, and stool antigen tests enable accurate identification of H. pylori infections, facilitating timely intervention that leads to improved patient outcomes. Early treatment can alleviate symptoms, expedite ulcer healing, and avert severe complications like stomach cancer. The availability of non-invasive and cost-effective testing options increases accessibility for a broader patient population. Moreover, the treatment landscape includes a variety of effective antibiotics and acid-reducing medications that not only alleviate symptoms but also mitigate the risk of peptic ulcers, ultimately enhancing patients' quality of life.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Helicobacter Pylori H. Pylori Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Helicobacter Pylori H. Pylori Diagnostics Market Segments Analysis

Global Helicobacter pylori H. pylori Diagnostics Market is segmented by Test Type, Method, End User and region. Based on Test Type, the market is segmented into Invasive, Histology, Rapid Urease Test, HP Culture, Non-Invasive, Serologic Test, Urea Breath Test and Stool Antigen Test. Based on Method, the market is segmented into Immunoassays, Molecular diagnostics, Point of Care (POC) and Others. Based on End User, the market is segmented into Hospitals, Clinics, Diagnostic Labs and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Helicobacter Pylori H. Pylori Diagnostics Market

The global market for H. pylori diagnostics is primarily driven by the high prevalence of H. pylori infections worldwide, affecting nearly half of the global population. This widespread occurrence of one of the most prevalent bacterial infections has led to an increased demand for reliable diagnostic tests and effective treatment solutions. Healthcare professionals and patients alike are recognizing the necessity of accurate diagnosis to mitigate health complications associated with the infection. Consequently, the growing awareness and focus on managing H. pylori infections are propelling the market forward, emphasizing the need for innovative diagnostic tools and therapies to address this public health challenge.

Restraints in the Global Helicobacter Pylori H. Pylori Diagnostics Market

The expansion of the global Helicobacter pylori diagnostics market may face challenges due to the inadequate availability of healthcare resources and diagnostic tools, particularly in developing nations. Diagnosing and treating H. pylori infections typically requires specialized equipment and medical skills that may not be readily accessible in some areas. This lack of resources can significantly hinder market growth, as patients in these regions may struggle to obtain the necessary medical care. Consequently, the overall progress of H. pylori infection management could be stunted, limiting the market's potential to thrive and impacting patient outcomes in affected populations.

Market Trends of the Global Helicobacter Pylori H. Pylori Diagnostics Market

The Global Helicobacter Pylori (H. pylori) diagnostics market is experiencing a significant upward trend, primarily driven by a growing preference for non-invasive diagnostic methods, including serology tests and urea breath tests. This shift is fueled by increasing awareness of H. pylori's role in gastrointestinal diseases and the rising incidence of related conditions such as peptic ulcers and gastric cancer. The convenience and comfort of these minimally invasive tests are propelling their adoption among healthcare providers and patients alike. Additionally, advancements in technology and the integration of rapid testing options are further enhancing market growth, positioning non-invasive diagnostics as the preferred choice in H. pylori detection.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Helicobacter pylori H. pylori Diagnostics Market Size by Test Type & CAGR (2025-2032)

• Market Overview
• Invasive
• Histology
• Rapid Urease Test
• HP Culture
• Non-Invasive
• Serologic Test
• Urea Breath Test
• Stool Antigen Test

Global Helicobacter pylori H. pylori Diagnostics Market Size by Method & CAGR (2025-2032)

• Market Overview
• Immunoassays
• Molecular diagnostics
• Point of Care (POC)
• Others

Global Helicobacter pylori H. pylori Diagnostics Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Clinics
• Diagnostic Labs
• Others

Global Helicobacter pylori H. pylori Diagnostics Market Size & CAGR (2025-2032)

• North America (Test Type, Method, End User)
  • US
  • Canada
• Europe (Test Type, Method, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test Type, Method, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test Type, Method, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test Type, Method, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meridian Bioscience (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Epitope Diagnostics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biohit Oyj (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avanos Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quidel Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratory Corporation of America Holdings (LabCorp) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations